For the trial, the company has partnered with Pennard Vets in Kent, where they're using Google Glass to transmit what the practitioner sees straight to the consulting experts at VetCT.
The remote VetCT specialist is able to view and remotely record, zoom, adjust lighting, annotate and send images back for the wearer of the glasses to view.
They are also able to discuss the case live with team in the clinic.
As part of the trial, images streamed via the glasses are being compared against those shot on a higher resolution mobile phone.
Director and Innovation Lead at VetCT, Julien Labruyère said: “We have a tremendous resource of specialist knowledge and expertise within our global team, and are exploring new ways to maximise the potential benefits of real-time clinical mentoring, teaching and case support.
"This first step we have taken with Google Glass marks the start of an exciting journey to make smart glasses technology useful to help vets in practice."
Caroline Collins, Director at Pennard Vets, said: “Trialling the glasses has been a fascinating exercise. We’re now looking at cases where we could see the most benefit from real-time specialist feedback and hands-free capability. It could be a real game-changer in some situations, for example with remote guidance of patient examinations or complex procedures.”
To learn more about VetCT visit www.vet-ct.com.
The new scanner takes scans 50% faster and at a far higher resolution than the outgoing model.
It also boasts a wide bore magnet, simple coil arrangement and large number of channels, which means clinicians can scan different organ systems in patients of all shapes and sizes.
Cave says the new equipment allows it to expand into emerging fields such as cardiac MRI and advanced musculoskeletal imaging.
Tom Cardy, head of neurology, said: “It’s not often in your career you get to work with a truly class-leading piece of equipment such as this.
“The new scanner will greatly improve the patient and client experience we provide. This investment significantly increases the capability of our neurology service and the whole team are excited to get to grips with this amazing piece of kit.”
For more information, visit https://cave-vet-specialists.co.uk.
Photo: L-R Radiographer Tracy Down and imaging nurse Staci Finn
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
The group, which opened in 2021, is also securing sites in Newcastle and Halesowen for a further two practices which are due to open in 2026.
Harrison Family Vets says at least £350,000 will be invested in each of the new practices which will be staffed by a team of six initially.
Operations director, Kristie Faulkner said: “In less than four years we’ve opened seven extremely successful practices and quickly established a reputation for being a great place to work.
"We’ve built a team where everyone’s individual strengths and personality traits contribute to what we do, in a family-orientated environment.
“We take pride in creating very modern and well-equipped surgeries that are designed around the pets we treat, and we push the boundaries of what’s possible when it comes to pet care.
"In addition, all our team members are also trained, or currently in training for, the Fear Free Accreditation, to significantly reduce fear, stress and anxiety for both pets and their owners, which means every pet’s visit to Harrison Family Vets is as positive as possible.
“Crucially, we also offer pet owners far more affordable pet care than the large corporate chains and our total wellness plan is one of the best value offerings on the market.
"When this is combined with our exceptional team and pioneering practices, it’s not unusual for us to have hundreds of pet owners registering with us in new locations before we even open.
“We’re now looking forward to embarking on our next phase of growth and making our unique offering available to even more veterinary professionals and pet owners throughout the country.
"We would urge anyone interested in joining us in Stoke, Sheffield or Darlington, as well as Newcastle or Halesowen, which will launch in the next phase of openings, to contact us now.”
https://www.harrisonfamilyvets.co.uk/
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com
Kruuse UK has announced the launch of its new Mud Fever Kits for horses.
Kruuse says the launch follows independent studies last year by Aimi Duff BVM&S, MRCVS (Scott, Mitchell & Associates, Hexham) on the use of Manuka ND dressings for the treatment of Mud Fever.
The kit contains one complete treatment for two legs (or two complete treatments for one leg) including all dressings. There is also a step-by-step guide from the "Ask the Vet" series which explains best treatment protocol, designed to help veterinary surgeons dispense the kit directly to clients with confidence.
According to the company, the benefits of using medical grade Manuka Honey in the treatment of Mud Fever include:
Andrew Groom, Managing Director of Kruuse UK Ltd said: "We are delighted with the initial response to our unique Mud Fever Kits; such additions to our range continue to enhance the Kruuse commitment to equine wound care."
The new voice skill offers three main features, a chocolate toxicity calculator for dogs, the nearest emergency vet finder, and answers to Vets Now's commonly asked pet health questions.
Head of clinical intelligence at Vets Now, Dave Leicester said: “With many people reluctant or not able to leave their homes due to the coronavirus pandemic, we're making veterinary advice accessible to everyone, through as many channels as possible including our website, video vet service, and now smart speakers.
"We fast-tracked our plans for the innovative voice skill in response to Covid-19 as we know how much pet owners are relying on remote veterinary advice just now — we’ve seen a huge spike in calls to our emergency contact centre and the uptake of our new video triage consultation service has been exceptional, with more than 500 video calls from worried pet owners since its launch in April.
"Our new voice skill is the next step in helping pets and their owners as much as we can during this incredibly difficult time. It’s a first release of the skill but we will continue to build and add advice to it in the weeks and months ahead.”
More information on the veterinary advice skill and how to access it can be found here www.vets-now.com/smart-speaker.
COMMENTI've just tried the new skill, and my first impression is that vets don't have to fear this is going to put them out of a job any time soon.
As with all things Alexa, there is a sporting chance she'll mishear what you said. But the bigger problem is that it may be a solution to a problem that doesn't exist.
I've had a dog for the last decade, and I could count the number of times I had a question for the vet that could be answered by an app on the fingers of one finger.
In fact, it was the time our dog ate chocolate.
But would I download a voice assistant just to answer the chocolate question?
No, I wouldn't.
Nor would I download a voice assistant to explain veterinary conditions, simply because I don't have questions of that nature more than once a decade. Who does? And if I wanted to know where the nearest emergency vet was, I'd either Google it or I'd ask Alexa herself (as opposed to summoning the Vets Now voice assistant specifically).
The sentiment behind this idea - making advice more accessible - seems sound, but I suspect that unless this assistant becomes truly encyclopaedic, it is never going to be useful enough to warrant installing on a smart speaker. Even then, one has to wonder whether the average pet owner has enough animal-related questions every month to warrant having an assistant to answer them.
The Disciplinary Committee took the unusual step of granting an application by the respondent for anonymity, after seeing evidence of a real and immediate threat to the individual’s security if their details were made public.
For the purposes of the hearing, the respondent was therefore referred to as 'X'.
The Committee heard that the individual pleaded guilty in court in 2020 to intentionally and knowingly attempting to communicate with a person under 16 years for the purposes of sexual gratification.
Following this they were sentenced to a two-year probation order, were ordered to register on the Sexual Offences Register for five years; and were made subject to a Sexual Offences Prevention Order for five years.
At the outset of the hearing the individual admitted to all the charges against them and the Committee also noted that there was a certified copy of the conviction available.
The Committee then considered whether the conviction amounted to serious professional misconduct. In considering this, it set out the aggravating factors surrounding the case, these being that there was the risk of actual harm to a minor, that the misconduct was premeditated as the respondent had sent a number of messages via a number of online platforms over several days, that the individual displayed predatory behaviour including sending pictures and making comments of a sexual nature, and that it involved what the respondent believed to be a vulnerable individual, namely a 15-year-old child.
In mitigation, the Committee considered that there had been no actual harm caused to a human or animal in light of the fact that the 15-year-old child, who the respondent believed they were communicating with, was not real. It also took into account that the conduct related to a single isolated incident and that the individual had made open and frank admissions at an early stage.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee was satisfied that the sentence imposed on X, which included X being subject to a Sexual Harm Prevention Order until 2025, resulted in the profession of veterinary nurses being brought into disrepute and, in the Committee’s judgement, public confidence in the profession would be undermined if the Committee did not find that the conviction rendered X unfit to practise as a veterinary nurse.”
In considering the individual’s sanction, the Committee heard from a character witness who said that the respondent’s actions were out of character, that they had a previously long and unblemished career, that they had made full admissions and demonstrated insight, and that they had a low risk of reoffending in the future.
Cerys said: “The Committee accepted that X had been an excellent veterinary nurse and that X’s criminal conduct did not relate to X’s practice as a veterinary nurse. However, in the Committee’s judgement, the aggravating factors outweighed the considerable mitigating factors in this case.”
She added: “The Committee decided that a suspension order was not the appropriate sanction for such a serious offence because it did not reflect the gravity of X’s conduct. In the Committee’s judgement, the wider public interest, that is the maintenance of the reputation of the profession and the College as a regulator, required a sanction of removal from the Register. The Committee considered that X had much mitigation and was clearly a dedicated veterinary nurse but the reputation of the profession was more important than the interests of X.
“Further, the Committee noted that in circumstances where X’s probation order expired in 2022, and where the ancillary orders, a Sexual Harm Prevention Order and a requirement to register on the Sexual Offences Register did not expire until 2025; the only proportionate sanction was to direct the Registrar to remove X’s name from the Register of Veterinary Nurses.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
Kruuse has launched a range of seven specialized sterile surgical disposable drapes and gowns developed for the surgery team working in equine clinics or hospitals.
The company says its new surgical sets have been designed so they include a comprehensive set of sterile drapes, towels, instrument covers and adhesive tapes needed to perform particular procedures:
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This exciting new range of products increase the Kruuse's equine product portfolio and develop further our commitment to provide specialist species available products to support the veterinary practitioner."
Petplan is calling for nominations for this year's 'Petplan Veterinary Awards 2011'.
The awards, which are now into their 12th year, are an opportunity for colleagues and pet owners to thank their local veterinary stars who go above and beyond the call of duty.
Alison Andrew, Petplan's Marketing Manager, said: "At Petplan, we work closely with vets and hear first hand about the incredible work that is carried out by the profession, so we believe that their invaluable care and support deserves special recognition. Nominating a colleague for an award is a fantastic way of expressing your appreciation for their hard work."
Alison added: "Last year, Petplan was inundated with over 1,800 nominations from across the UK, highlighting that more pet owners understand the great work vets do to help animals and their owners, and with 40% of pet-owners in the UK, stating that they trusted their vet more than their GP, it is not hard to see why the awards are so highly commended."
Closing date for entries is 4th February 2011. All finalists will be invited to a glittering awards ceremony in Birmingham on 31st March 2011, where the winners will be announced.
Winners will be selected based on the evidence given on the nomination forms by veterinary association presidents, so make sure you provide as much information as possible. To nominate today visit www.petplan.co.uk/vetawards
Petplan has announced the finalists for the 2011 Petplan Veterinary Awards.
Now in its 12th year, the Petplan Veterinary Awards received its biggest response yet with over 2,800 nominations submitted for exceptional veterinary staff all over the UK.
The finalists for each of the categories are as follows:
Vet of the YearCharles Bagnal, Orwell Veterinary Group - Ipswich Alison Laurie, Crown Vets - Highlands Daniel Parry, Village Vet Garden Suburb - London
Vet Nurse of the YearEmma Clare, Copthorne Veterinary Clinic - Shropshire Maria Corcoran, Orwell Veterinary Group - Ipswich Ingrid Hunt, Cranbrook Veterinary Centre - Devon
Support Staff of the YearBev Millward, Milton Keynes Veterinary Group - Milton KeynesLauren Hunter, The Ferns Veterinary Practice - Dunkeld Patty Fraser, Loch Leven Equine Practice - Kinross
Vet Practice of the YearAshfield House Veterinary Hospital Ltd - Nottinghamshire Emersons Green Veterinary Surgery Ltd - Avon Leonard Brothers Veterinary Centre Ltd - Shropshire
Alison Andrew, Petplan's Marketing Manager, said: "The nominations get bigger and better every year and we're absolutely delighted to announce the finalists for 2011. With 70% of veterinary practices within 3 miles of their patients, veterinary staff are an important part of the community and that's why we feel it important that they have a chance to receive the recognition they deserve. We're looking forward to revealing the winners on 31st of March."
All finalists will be invited to an elegant awards ceremony that will take place on 31st March at the Birmingham Town Hall, where the winners will be announced.
For further information, visit http://www.petplanvet.co.uk/
New research from the Animal Health Trust (AHT), published in the Equine Veterinary Journal, shows that equine obesity is an increasing but under-recognised welfare issue in the UK.
Data collected from 785 horses and ponies (31% of which were classified as obese), over a two-year period between 2009 and 2011, has been used to explore various elements that contribute to the risk of obesity in British horses and ponies.
The research, funded by World Horse Welfare, identified several factors which may increase the risk of being obese. Pony breeds, particularly UK native breeds and heavier horses such as draught and cobs types were all significantly more likely to be obese compared to Thoroughbred horses. Charlotte Robin, Research Assistant at the AHT and lead author of the paper, said: "Native breeds may be genetically better adapted to survive in harsh conditions, having a so-called thrifty genotype, increasing their risk of obesity when maintained in an environment where food is of better quality and more readily available."
Horses that were described by their owners as readily being able to gain weight or being "good doers" were more than three times more likely to be obese, compared to those that normally maintained weight.
The research also highlighted various links to human obesity. Charlotte said: "In humans, obesity is associated with poor health status and chronic health conditions including diabetes, hypertension, respiratory disease and arthritis. Similar associations between obesity and adverse health events have been described in equines."
Similarly in humans, exercise significantly improves insulin sensitivity, and it is thought the same "dose-response" effect is mirrored in horses. For example, the AHT's research highlighted that the risk of obesity is greater in pleasure or non-ridden horses, with pleasure horses being more than twice as likely to be obese and non-ridden horses being nearly three times more likely to be obese. Competition animals will receive increased exercise at a higher intensity and be fitter than non-competition animals, further reducing the risk of obesity. Charlotte added: "Competition horses are likely to be managed in different ways compared to non-competition or non-ridden animals and this may also contribute to the reduced risk of obesity within this sub-population."
World Horse Welfare's Deputy Head of UK Support, Sam Chubbock said: "Excess weight is one of the greatest challenges facing horse owners in the UK today, which is why we supported this vital research. Being overweight can be just as much, if not more, of a health concern as being underweight. In our experience it can take three times longer to get an overweight horse back to optimum condition than it can a thin horse. Moreover, a previously obese horse's weight will need to be managed for the rest of its life, even after the weight has come off, and they are likely to suffer long-term effects. Managing a horse prone to weight gain can be incredibly difficult and this is why our Right Weight project provides practical guidance for owners on how to assess and manage their own horse's weight."
The AHT says its obesity research has helped to highlight obesity as a significant equine welfare issue and provided valuable information for owners. People frequently misclassify their own weight or body shape, and this phenomenon also applies to perceptions about our pets' weight. Dog and horse owners have been demonstrated to underestimate their animals' weight, suggesting the prevalence of obesity in this study is likely to be an underestimation.
Charlotte said: "It is possible that in certain breeds, being overweight or obese has been normalised to a certain extent. Owners may find it easier to identify an overweight Thoroughbred, compared to an overweight cob or native pony.
"Helping owners identify when their horse is overweight or obese is an essential aspect of reducing the welfare impact of equine obesity."
Reference
The company says the webinars will equip veterinary professionals with strategies to strengthen wellbeing both individually and for practice teams.
Lauren Hayes, Scientific and Regulatory Affairs Manager at Royal Canin, said: “Working within clinical veterinary practice can be hugely rewarding and enriching, but it cannot be ignored that our industry also has its challenges.
"Veterinary surgeons have a significantly higher risk of suicide compared to the general population and mental health issues around work life balance and compassion fatigue are widespread.
"Through our webinar series, we hope to encourage conversations around mental health and help provide advice directly from leading experts.”
The one-hour webinars will take place at 7pm every Wednesday throughout September.
https://vetportal.royalcanin.co.uk/news/new-veterinary-professional-health-webinar-series/
The company says the Elekta Infinity linear accelerator is the only one of its kind for pets in England.
It features a multi-leaf collimator for very accurate shaping of the radiation beam and a six-degrees-of-freedom couch top designed so the patient can be positioned to reduce or eliminate radiation doses to critical organs.
CVS says the new machine will allow the centre to offer cutting edge treatments such as stereotactic radiation therapy, where high dose rates of focused beams are delivered with high precision over a shortened treatment course.
This, the company claims, will mean fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital will be at the forefront of cancer care in animals.
“The linear accelerator is state of the art, and allows us to offer advanced, image-guided radiation treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage to these treatments is that they will allow a more “hard-hitting” treatment of the tumour, with greater safety for the patient’s healthy tissue.
"It will draw many tumours into the realm of treatability.”
Based at Central Park, Avonmouth, Bristol Vet Specialists referral hospital is due for completion this Autumn.
For the study, 12 month's worth of anonymised data from CVS practices was analysed2.
The study concluded that lower engagement between a practice and its staff or clients, recent parental leave, shorter practice employment tenure, and younger age were all associated with an increased likelihood of support staff resignations.
Lower practice client engagement, which CVS says is a proxy for client satisfaction, was associated with increased odds of support staff resigning3, highlighting the potential impact of client incivility on veterinary colleagues who are typically in customer facing roles.
Reduced employee engagement – measured by a ‘employee net promoter score’ (eNPS), where colleagues rate how likely they would recommend the practice as a good place to work4, also correlated with increased resignations.
Within CVS, eNPS has been demonstrated to be positively correlated with the frequency of line manager discussions.
The current data suggests that consistent measurement of employee engagement in a veterinary setting at regular intervals throughout the year can have benefits for line managers in identifying increases in the risk of resignations and practice attrition, allowing them to take proactive steps to improve engagement.
A recent record of taking parental leave was also associated with greater odds of resigning in the following 12 months than staff who have not taken parental leave in the previous 12 months5.
Qualitative studies in other professions highlight the need for greater flexibility in working hours and focused managerial check-in support.
Therefore ‘return to work’ interventions may present an opportunity to improve retention.
Conversely, the increased length of employment tenure was associated with decreasing odds of support staff resignations6, potentially highlighting the role for long service reward schemes, such as the long service holiday awards CVS introduced a couple of years ago. Whilst employee age was associated with the odds of resignations, with a 1% decrease in the odds of support staff resigning with each additional year of age7.
Imogen Schofield, Director of Clinical Research at CVS, said: “Support staff are integral members of the team.
"These key roles contribute to the efficient and effective functioning of a veterinary practice.
"Despite the important roles of support staff, little research exists on these team members and there is no data describing reasons for their attrition.
“This research was done to help the wider industry to understand how we can reduce support staff resignations.
"It aims to identify demographic, payroll and engagement factors associated with resignations.
"We believe it adds valuable insights to previous survey-based research by organisations such as the British Veterinary Receptionist Association.
“Reflecting on our research from 2021, we have introduced a Zero Tolerance Policy to protect our colleagues against intrusive, offensive, violent or aggressive behaviour from clients.
"We have launched monthly interactive Receptionist Support Sessions, giving receptionists the opportunity to connect with their peer network, share experiences and ideas, and feel supported.
"And we are now focussing on developing our support staff through creating new Receptionist and Patient Care Assistant Career Pathways.”
References
The majority of posters, leaflets and other displays in veterinary practice waiting rooms are more effective at building ambience than increasing the turnover of the practice or selling a particular product or brand, according to a new survey carried out by veterinary marketing agency TMA.
The national survey of more than 100 veterinary practice managers found that:
TMA says it believes practices are missing out on a major marketing opportunity by not changing their displays more often, not being more selective about what is displayed, and not making the most of interactive or digital display technology.
Helen Cawthra, Managing Director of TMA believes that product manufacturers are also missing out on a major opportunity. Significantly less than half of all display and point-of-sale material in vets' waiting rooms is provided by suppliers. On average, 64% is sourced by the veterinary surgeons themselves.
Helen said: "Two thirds of respondents claim that they hardly get any materials from suppliers. The same number claim they would be more likely to put up more if they were provided with it.
"It is all very well building ambience and providing loyalty but in today's market, it is important that vets take hold of every opportunity to generate revenue in every way possible. Vets and the manufacturers are both missing out."
The RCVS is now accepting disclosures from veterinary surgeons about any criminal cautions, convictions or adverse findings they may have against them, as part of a voluntary period before the requirement to disclose commences in 2014.
The requirement that veterinary surgeons notify the College about criminal cautions, convictions or adverse findings on registration, and on an annual basis as part of their registration renewal each March, was introduced as part of the Code of Professional Conduct in 2012 (section 5.3, see Notes to Editors). However, the College has allowed a bedding-in period for the Code before enforcing the requirement.
From 2014, new registrants will have to disclose any criminal cautions, convictions or adverse findings that may affect registration (for example, those from university fitness to practise procedures).
Veterinary surgeons already on the Register (including overseas and non-practising categories, as well as UK-practising) will only be required to disclose criminal cautions, convictions or adverse findings that have occurred since April 2006. Fixed-penalty motoring offences are excluded.
The veterinary profession has fallen under the Notifiable Occupations Scheme since April 2006, which means that serious convictions are already passed to the College from the police.
If a veterinary surgeon declares a criminal conviction, this will be initially considered by the Registrar, and, if necessary, referred to the Preliminary Investigation Committee. In some cases, the matter will be referred on to the Disciplinary Committee to decide if the nature of the caution or conviction affects the veterinary surgeon's fitness to practise - in which case the usual sanctions of removal or suspension from the Register could apply.
Eleanor Ferguson, Head of Professional Conduct said: "We hope, through this new requirement, to increase the public's confidence in the veterinary profession, and to safeguard animal health and welfare. The move brings the veterinary profession into line with many others - including registered veterinary nurses, who have made such a disclosure since their Register was introduced, in 2007."
The RCVS has launched a dedicated advice line to assist affected veterinary surgeons, on 07818 113 056, open Monday to Friday, 11am-4pm.
Callers will speak to one of three RCVS solicitors who can advise on the process and the possible outcomes of disclosure. Alternatively, veterinary surgeons can contact disclosure@rcvs.org.uk.
Detailed information regarding the requirement, including examples of the kinds of convictions that may be referred to the Preliminary Investigation Committee, and a disclosure form, can be found on www.rcvs.org.uk/convictions.
The pack highlights the benefits of Adaptil and Feliway and Ceva’s ThunderShirt range of calming wraps.
It contains a wall/notice board display, a poster, an e-book and leaflet for owners, and a social media toolkit with graphics and pre-written posts for practices to use on their own social media channels.
The company is also running its fireworks waiting room display competition this month, in which the five veterinary practices who make best use of the materials for creating a display in their waiting room will win one of five £100 Love 2 Shop vouchers.
There are bonus points for practices that build a den in the waiting room to demonstrate the benefits of having a safe haven for dogs to retreat to when fireworks are going off.
Veterinary professionals can post pictures of the dens and waiting room displays on the Adaptil Facebook page throughout October - www.facebook.com/AdaptilForDogs.
Ceva is running commercial offers in the run up to the firework season, which practices are being encouraged to pass to their clients.
To download the fireworks marketing support pack go to http://bit.ly/3RxGLza.
For further information, contact your Ceva territory manager or email cevauk@ceva.com.
International Cat Care has launched a competition in which veterinary practice staff are invited to take a 'selfie' of themselves with their favourite cat and upload it to the International Society of Feline Medicine (ISFM) Facebook page (www.facebook.com/ISFMcats), where cat lovers from around the world can vote for their favourite.
The Cattitude competition is designed to raising awareness of the charity's global Cat Friendly Clinic initiative.
The photograph that gets the most Facebook 'likes' will be used by the charity to help raise awareness of the Cat Friendly Clinic programme, which aims to promote the wellbeing of cats visiting or being hospitalised in a veterinary practice. Accredited Cat Friendly Clinics fulfil a set of broad criteria that show they recognise the specific needs of cats and their owners, and place cat welfare high in their practice priorities. Cat owners in turn are able to seek out clinics that have taken steps to help them overcome common barriers to clinic visits and reduce the stress of their pet.
The Cattitude competition runs from now until the 24th April. The winning staff member will receive £200 worth of John Lewis vouchers and the practice £400 worth of Thames Medical vouchers to be spent on feline-friendly equipment.
Practices may upload as many photos as they like to the Facebook page, and will be able to encourage clients to 'Like' their photos with campaign support materials which include downloadable in-clinic display posters, a series of supplied posts for their own Facebook page, written copy for their own clinic newsletter or email along with a proforma press release they can send to their local newspapers and publications.
Clinics can find more information on taking part in the Cattitude competition at www.facebook.com/ISFMcats orwww.icatcare.org/cattitude. Details of the ICC Cat Friendly Clinic initiative and accreditation can be found atwww.catfriendlyclinic.org along with a list of already-accredited vet clinics.
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life and that the onset of immunity for BRSV is 6 days (for calves vaccinated from the day of birth onwards) and 5 days (for calves vaccinated from the age of one week onwards).
Onset of immunity for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.
From a practical standpoint, the new license means Bovilis Intranasal RSP Live can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements.
Additionally, Bovilis Intranasal RSP Live can be used up to six hours after mixing with the solvent, which MSD says is the longest of all the available intranasal vaccines for these pathogens.
The vaccine is supplied as a nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.
The vaccine is available in 5x1 dose, 5 dose and 5x5 dose packs.
Developed in partnership with the Veterinary Client Mediation Service (VCMS), the course uses practical examples based on real-life experiences.
The course shows how to assess complaints from a client’s perspective and how building client relationships can help defuse complaints.
Jennie Jones, Head of VCMS, said: "Leveraging insights from the VCMS and involving our entire team with its production has enabled us to develop highly effective materials that ensure veterinary professionals are well-equipped to manage complaints."
The course takes one hour to complete.
academy.rcvs.org.uk
The self-adhesive dressing, which uses a patented natural polymer, adapts to any part of the body and sets fast, acting as a waterproof barrier to the external environment which shields the site from unwanted moisture and bacterial ingress and allows the tissue underneath to repair in a protected environment.
It is proven to prevent the loss of therapeutic sprays when it is used as a barrier1.
The company says NoBACZ Bovine is easy to apply with a clean gloved hand and offers up to seven days’ protection without the need to reapply.
It is suitable for use on any site of the body, except the eyes, and has been especially widely used on hooves, horn buds and udders.
The liquid barrier dressing does not need to be removed as it will self-degrade and its ingredients dissolve naturally with no residue.
Dr Jonathan Powell, Director of Biomineral Research and Imaging at the University of Cambridge’s Department of Veterinary Medicine, and chief executive officer and co-founder of NoBACZ Healthcare, said: “Following several years of research at the University of Cambridge and comprehensive market analysis which identified an unmet need across the farming industry, we are absolutely delighted to launch NoBACZ Bovine, which offers unparalleled protection against harsh farm conditions, revolutionising wound protection in cattle and enhancing the health and welfare of the national herd.”
Mike Kerby, veterinary surgeon from Synergy Farm Health, who has used NoBACZ Bovine over many months, added: “I have been using NoBACZ Bovine for a while in cattle affected with UCD (udder cleft dermatitis) and DD (digital dermatitis) lesions as well as on wounds and granulomas.
"It is my clinical impression that it counters bacterial colonisation rapidly and promotes re-epithelialisation, which in turn helps to prevent the occurrence of proud flesh or reduces the mass of any existing granulomata.
"Application is simple and quick, with clients also finding it easy to reapply regularly within set treatment protocols.
"In addition to this, it was seen as a huge advantage that bandages and their removal are not involved, nor are antibiotics, making it labour saving, sustainable and eco-friendly.”
www.nobacz.com